Alliance Pharma (APH)

 28.38p
   
  • Change Today:
      0.000p
  • 52 Week High: 31.75
  • 52 Week Low: 26.25
  • Currency: UK Pounds
  • Shares Issued: 240.11m
  • Volume: 579,735
  • Market Cap: £68.13m
  • RiskGrade: 73
  • Beta: 0.19

Latest ShareCast News

Alliance Pharma shares fall sharply, in part due to macro concerns

Date: Monday 16 Jan 2012

Speciality pharmaceutical company Alliance Pharma has this morning announced its pre-close trading update for the year ended on the 31st of December of 2011.

Alliance Pharma Regulatory News

AGM Statement 23-May-2012 07:00 RNS
Notification of Major Interest in Shares 14-May-2012 11:09 RNS
Notice of AGM 10-Apr-2012 12:01 RNS
Annual Report and Accounts 27-Mar-2012 09:00 RNS
Preliminary Results 22-Mar-2012 07:00 RNS

Alliance Pharma News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 28.38p
Change Today 0.000p
% Change 0.00 %
52 Week High 31.75
52 Week Low 26.25
Volume 579,735
Shares Issued 240.11m
Market Cap £68.13m
Beta 0.19
RiskGrade 73

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.45% above the market average18.45% above the market average18.45% above the market average18.45% above the market average18.45% above the market average
91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average
Price Trend
29.58% below the market average29.58% below the market average29.58% below the market average29.58% below the market average29.58% below the market average
21.43% below the sector average21.43% below the sector average21.43% below the sector average21.43% below the sector average21.43% below the sector average
Income
6.99% above the market average6.99% above the market average6.99% above the market average6.99% above the market average6.99% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
34.90% above the market average34.90% above the market average34.90% above the market average34.90% above the market average34.90% above the market average
6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 2
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 13-Jun-12 30-Nov-11
Paid 12-Jul-12 13-Jan-12
Amount 0.50p 0.25p

Trades for 30-May-2012

Time Volume / Share Price
12:34 467,857 @ 28.25p
11:39 5,000 @ 28.46p
11:22 8,000 @ 28.31p
11:12 48,500 @ 28.75p
11:11 50,000 @ 28.50p

Alliance Pharma Key Personnel

CEO John Dawson
Finance Director Richard Wright

Top of Page